6 to 8pm
The market for products and technologies related to the human microbiome is rapidly developing and expanding. But how much do we really know about the plethora of microbial inhabitants in our bodies, and how can we use this knowledge to treat human disease? Come learn how two local companies, Siolta Therapeutics and Epibiome, are approaching this therapeutic space and addressing business-related considerations in the microbiome industry.
Nikole Kimes, PhD, VP of Siolta Therapeutics
Bruno Marchon, PhD, CTO of Epibiome, Inc.